What Data Trained Your AI?
Data Products
AI-Enriched Real-World Data Products
Structured AI Insights for Large-Scale Analyses
RWD360™
RWD360™ is a vast repository of pan tumor clinical data for broad analyses with the highest epidemiological relevance. Validated AI models enrich data for scale; claims linkage provides more complete insights into patient journeys.
All Solid Tumors and
Hematologic Malignancies
Broad Geographic
Coverage
AI-Enriched and
Sophisticated Models
Reasons for RWD360™
Request InformationCompare Characteristics
Compare demographic characteristics based on different treatments.
See Treatment Sequencing
See how treatments and drug class exposures being sequenced in a cohort.
Combine Clinical Criteria
Understand which patients have a combination of clinical criteria (like ECOG, stage, laboratory tests, and smoking status) and see the distribution of values for the cohort.
Customer Value for RWD360™
Clinical Development Leaders
Rapidly generate insights into standard of care with on-demand access to thousands of data elements and accelerate innovation and drug development timelines.
Data Scientist & Trial Analytics Experts
Use advanced analytics and data science integrated with large real-world datasheets to work in new ways and optimize study design and execution.
Chief Development Officers
Centralize enterprise data needs with the ability to easily combine disparate datasets and shorten clinical development workflows with rich data and data science technologies.
Expertly Abstracted Data for Research Purposes and Publication
Patient360™
Patient360™ is an off-the-shelf, deeply abstracted data product that removes the need for bespoke curation and allows direct insights into current standard of care on emerging disease and treatment dynamics.
Deepest Industry Abstraction
On-Demand Datasets
Reasons for Patient360™
Request InformationIdentify Study Feasibility
Identify base rates of clinical characteristics, disease severity measures and treatment outcomes in real world treatment to inform the feasibility of using RWD as a comparator arm.
Post-Approval RWD
Conduct effectiveness outcomes studies in specific populations of interest and compare to clinical trials.
Track Safety
See adverse events experienced by real-world populations and compare to clinical trials.
Customer Value for Patient360™
Clinical Development Leaders
Rapidly generate relevant insights into standard of care, develop novel research studies, and shorten drug development timelines.
Post-Approval/Epi-Safety Executives
Bring automation and data science to post-marketing analytics, comparative effectiveness studies, and risk surveillance.
Brand Managers
Assess and monitor treatment journeys and adherence patterns for strategic development and post-launch planning
Which Cancers Can I Research?
Research Study
Performance of Proxy Measures Compared with Direct Observation of Progression-Free Survival
See results from findings presented at ISPOR 2020 and ASCO 2020 on the performance of proxy measures against directly-observed measures of PFS by using structured and unstructured information from ConcertAI’s Oncology Real-World Database.
See Research Study
Deep Clinico-Genomics Data
Genome360™
Genome360™ provides in-depth understanding of treatment profiles with data from NGS panels and structured and unstructured fields.
Full NGS Panel
Linked Clinical-Genomic
Deepest Industry Abstraction
Reasons for Genome360™
Request InformationBiomarker Testing Results
See biomarker testing, results, and timing and understand trends and how they change over time.
Identify Patients by Gene Variants
Identify patients by any type of variant in a given gene, e.g. mutation, amplification, rearrangement, etc.
Assess Treatments and Outcomes
Assess how testing (and additionally, positivity) affects treatment selection and outcomes.
Customer Value for Genome360™
Clinical Development Leaders
Rapidly generate relevant insights into standard of care, develop novel research studies, and shorten drug development timelines.
Post-Approval/Epi-Safety Executives
Bring automation and data science to post-marketing analytics, comparative effectiveness studies, and risk surveillance.
Brand Managers
Assess and monitor treatment journeys and adherence patterns for strategic development and post-launch planning.
Tailored Abstraction & Analytics
Custom Data Services for Specific Research Needs
Our team of HEOR and clinical oncology experts build unique data assets to support research questions that demand deeper insights.
Oncology and HEOR Expertise
Extensive Knowledge of RWD
Biostatistical Design and Execution
Regulatory Support and Publications
Reasons for ConcertAI Custom Data
Request InformationPrecise Patient Journeys
Create bespoke datasets to explore the real-world treatment landscape
Depth of Information
Customize datasets for granular insights into specific outcomes and endpoints
Longitudinal Datasets
Commission datasets to function as EMR registries